Kinaxis Inc. (TSE:KXS – Get Free Report) Senior Officer Christopher John Blaine Fitzgerald sold 2,003 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of C$185.05, for a total value of C$370,656.55.
Kinaxis Stock Performance
Kinaxis stock opened at C$185.98 on Thursday. The company has a debt-to-equity ratio of 12.40, a current ratio of 1.90 and a quick ratio of 2.29. Kinaxis Inc. has a 12 month low of C$132.93 and a 12 month high of C$190.17. The company has a market cap of C$5.25 billion, a price-to-earnings ratio of 185.98, a price-to-earnings-growth ratio of 3.60 and a beta of 0.78. The stock’s 50-day moving average is C$166.79 and its 200-day moving average is C$158.62.
Kinaxis (TSE:KXS – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported C$0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of C$0.43 by C$0.04. The company had revenue of C$165.79 million during the quarter, compared to analyst estimates of C$170.56 million. Kinaxis had a net margin of 4.59% and a return on equity of 4.87%. Equities analysts anticipate that Kinaxis Inc. will post 4.2526231 earnings per share for the current year.
Analyst Ratings Changes
View Our Latest Report on Kinaxis
About Kinaxis
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Featured Stories
- Five stocks we like better than Kinaxis
- What is the Dow Jones Industrial Average (DJIA)?
- AutoZone Stock Stays in the Zone for Buy-and-Hold Investors
- 5 discounted opportunities for dividend growth investors
- 2 Robotic Surgery Stocks Challenging Intuitive Surgical’s Lead
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 of the Best Thematic ETFs for Investors in 2025
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.